While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get ...

DermTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always ...

DermTech stock is up more than 200% year to date after plunging in 2021 and 2022. The company announced big reimbursement deals with four private payers and Tricare. DermTech has bigger opportunities ...

LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the ...

DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various ...

Short interest for DermTech Inc gives investors a sense of the degree to which investors are betting on the decline of DermTech Inc's stock. Short interest data is updated every two weeks.

SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that ...

On August 3, DermTech International Registered will be reporting earnings from the last quarter. Wall Street analysts expect DermTech International Registered will be reporting losses per share of ...